CYP AND UGT INHIBITION TO ASSESS PERPETRATOR DRUG-DRUG INTERACTION POTENTIAL

被引：0
|
作者：
Zientek, Michael [1 ]
机构：
[1] Takeda Pharmaceut, San Diego, CA USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2024年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SC1.2
引用
收藏
页数：1
相关论文
共 50 条
  • [1] VALIDATED UGT INHIBITION ASSAYS TO ASSESS POTENTIAL DRUG-DRUG INTERACTION LIABILITY OF NEW CHEMICAL ENTITIES
    Chen, Kwang-Jong
    Gilbert, Jon
    Taimi, Mohammed
    DRUG METABOLISM REVIEWS, 2015, 47 : 108 - 108
  • [2] PBPK MODELING TO ASSESS DRUG-DRUG INTERACTION POTENTIAL OF VENGLUSTAT WITH CYP3A INHIBITORS
    Sharma, J.
    Li, L.
    Macha, S.
    Xu, C.
    Sahi, J.
    Zhang, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S74 - S74
  • [3] In vivo assessment of potential for UGT-inhibition-based drug-drug interaction between sorafenib and tapentadol
    Karbownik, Agnieszka
    Miedziaszczyk, Milosz
    Grabowski, Tomasz
    Stanislawiak-Rudowicz, Joanna
    Jazwiec, Radoslaw
    Wolc, Anna
    Grzeskowiak, Edmund
    Szalek, Edyta
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [4] DRUG-DRUG INTERACTION POTENTIAL OF ATEZOLIZUMAB AS A PERPETRATOR IN COMBINATION WITH THERAPEUTIC PROTEINS OR CHEMOTHERAPIES.
    Regan, S.
    Brumm, J.
    Chen, Y.
    Morrissey, K.
    Suchomel, J.
    Wang, N.
    Musib, L.
    Wu, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S49 - S49
  • [5] In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel
    Nishihara, Mitsuhiro
    Yamasaki, Hitomi
    Czerniak, Richard
    Jenkins, Helen
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (02) : 217 - 227
  • [6] Optimizing classification of drug-drug interaction potential for CYP450 isoenzyme inhibition assays in early drug discovery
    Krippendorff, Ben-Fillippo
    Lienau, Philip
    Reichel, Andreas
    Huisinga, Wilhelm
    JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (01) : 92 - 99
  • [7] ASSESS POTENTIAL DRUG-DRUG INTERACTION IN ADOLESCENT WITH MAJOR DEPRESSION DISORDER
    Lai, L.
    Dang, L.
    Vuong, D.
    VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [8] Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions
    Ben D. Snyder
    Andrew Rowland
    Thomas M. Polasek
    John O. Miners
    Matthew P. Doogue
    European Journal of Clinical Pharmacology, 2014, 70 : 1115 - 1122
  • [9] Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions
    Snyder, Ben D.
    Rowland, Andrew
    Polasek, Thomas M.
    Miners, John O.
    Doogue, Matthew P.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (09) : 1115 - 1122
  • [10] Drug-Drug Interaction Potential of Remimazolam: CYP 450, Transporters, and Protein Binding
    Petersen, Karl-Uwe
    Schmalix, Wolfgang
    Pesic, Marija
    Stoehr, Thomas
    CURRENT DRUG METABOLISM, 2024, 25 (04) : 266 - 275
12345